As HtrA-mediated E-cadherin shedding may possess cancer-promoting properties, we used the identified signature sites to design the first substrate-based peptide inhibitor to impede HtrA-mediated E-cadherin cleavage and H. pylori transmigration across a polarised monolayer. This evidence concerns the gene HTRA1 and cancer.